Rapid Drug Desensitization Study in Adults Experiencing Hypersensitivity Reactions to Palynziq

PHASE4RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
PhenylketonuriaPKU
Interventions
DRUG

RDD to Palynziq

Delivery of gradually increasing doses of Palynziq at fixed time intervals over the course of several hours to a cumulative dose equal to the reactive dose. Reactive dose is defined as the dose at which the reactive HSR occurred which led to treatment interruption or reduction of dose or dose frequency.

Trial Locations (1)

20815

RECRUITING

Uncommon Cures, Chevy Chase

Sponsors
All Listed Sponsors
lead

BioMarin Pharmaceutical

INDUSTRY